China Health Industries Holdings Inc
China Health Industries Holdings, Inc., through its subsidiaries, manufactures and sells health products. The company operates through three segments: Humankind, HLJ Huimeijia, and Others. The company offers hemp derivative products, such as hemp oil, hemp protein powder, hemp polypeptides, collagen peptides, hemp essence repair lotions, hemp revitalizing essence products, hemp anti-aging brighte… Read more
Market Cap & Net Worth: China Health Industries Holdings Inc (CHHE)
China Health Industries Holdings Inc (PINK:CHHE) has a market capitalization of $13.11 Million ($13.11 Million) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #45630 globally and #14321 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying China Health Industries Holdings Inc's stock price $0.20 by its total outstanding shares 65539737 (65.54 Million).
China Health Industries Holdings Inc Market Cap History: 2015 to 2025
China Health Industries Holdings Inc's market capitalization history from 2015 to 2025. Data shows growth from $9.83 Million to $13.11 Million (7.62% CAGR).
China Health Industries Holdings Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how China Health Industries Holdings Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
287.82x
China Health Industries Holdings Inc's market cap is 287.82 times its annual revenue
1.02x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $9.83 Million | $10.23 Million | $2.56K | 0.96x | 3838.72x |
| 2016 | $8.87 Million | $7.82 Million | $159.60K | 1.13x | 55.56x |
| 2017 | $19.66 Million | $6.37 Million | $1.31 Million | 3.09x | 14.99x |
| 2018 | $64.88 Million | $6.55 Million | -$317.00K | 9.90x | N/A |
| 2019 | $36.05 Million | $9.28 Million | $3.31 Million | 3.89x | 10.90x |
| 2020 | $28.84 Million | $9.93 Million | $3.55 Million | 2.90x | 8.12x |
| 2021 | $7.86 Million | $6.49 Million | $1.29 Million | 1.21x | 6.09x |
| 2022 | $11.14 Million | $267.00 | -$354.00K | 41729.42x | N/A |
| 2023 | $32.11 Million | $111.58K | -$409.00K | 287.82x | N/A |
Competitor Companies of CHHE by Market Capitalization
Companies near China Health Industries Holdings Inc in the global market cap rankings as of March 18, 2026.
Key companies related to China Health Industries Holdings Inc by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
China Health Industries Holdings Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, China Health Industries Holdings Inc's market cap moved from $9.83 Million to $ 13.11 Million, with a yearly change of 7.62%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $13.11 Million | -39.39% |
| 2024 | $21.63 Million | -32.65% |
| 2023 | $32.11 Million | +188.24% |
| 2022 | $11.14 Million | +41.67% |
| 2021 | $7.86 Million | -72.73% |
| 2020 | $28.84 Million | -20.00% |
| 2019 | $36.05 Million | -44.44% |
| 2018 | $64.88 Million | +230.00% |
| 2017 | $19.66 Million | +121.73% |
| 2016 | $8.87 Million | -9.80% |
| 2015 | $9.83 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of China Health Industries Holdings Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $13.11 Million USD |
| MoneyControl | $13.11 Million USD |
| MarketWatch | $13.11 Million USD |
| marketcap.company | $13.11 Million USD |
| Reuters | $13.11 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.